Core Viewpoint - The increasing involvement of insurance capital in bank equity is becoming a focal point in the capital market, highlighted by the recent acquisition of shares in Hangzhou Bank by New China Life Insurance [2][3] Group 1: Transaction Details - On June 10, Hangzhou Bank announced that New China Life Insurance acquired 329.6 million shares from the Commonwealth Bank of Australia at a price of 13.095 yuan per share, totaling 4.32 billion yuan [3] - Following the transaction, New China Life holds 5.09% of Hangzhou Bank's shares, while the Commonwealth Bank has completely exited its shareholder position after a 20-year relationship [3][4] - The shares acquired by New China Life are subject to a five-year lock-up period, and the transaction does not trigger a mandatory tender offer [3] Group 2: Strategic Implications - New China Life's investment is seen as a strategic move to enhance its asset allocation and strengthen its competitive position in the financial services sector, particularly in the Yangtze River Delta region [2][5] - The acquisition opens avenues for synergy between banking and insurance services, allowing for cross-business opportunities in wealth management, personal credit, and corporate pensions [5] - The exit of the Commonwealth Bank reflects a broader trend of foreign banks reassessing their strategies in the Chinese market, while local financial institutions are rapidly filling the void left by foreign capital [6][7] Group 3: Market Trends - The trend of insurance capital increasing its stake in bank equities is evident, with various insurance companies, including Ping An, actively acquiring shares in multiple banks [7] - The low valuation and high dividend yield of bank stocks make them attractive investments in a low-interest-rate environment, providing a hedge against interest rate risks [7] - Current data indicates that the average dividend yield for the banking sector is approximately 4.3%, with a price-to-book ratio of 0.67, suggesting a favorable investment landscape for insurance capital [7]

李琦强先生的离任不会导致董事会成员低于法定人数。李琦强先生确认其与 本公司董事会并无意见分歧，亦无任何需要通知本公司股东的事项，并将按照本 公司相关规定完成工作交接。本公司董事会对李琦强先生在任职期间所做出的贡 献表示衷心感谢！ 特此公告。 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任何 虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 新华人寿保险股份有限公司（以下简称"本公司"）董事会于 2025 年 6 月 10 日收到董事李琦强先生的辞职函，李琦强先生因工作原因辞去本公司非执行董事、 董事会审计与关联交易控制委员会委员、提名薪酬委员会委员及风险管理与消费 者权益保护委员会委员职务。 姓名 离任职务 离任时间 原定任期到 期日 离任原因 是否继续在上 市公司及其控 股子公司任职 是否存在未 履行完毕的 公开承诺 李琦强 非 执 行 董 事，董事会 审 计 与 关 联 交 易 控 制 委 员 会 委员、提名 薪 酬 委 员 会 委 员 及 风 险 管 理 与 消 费 者 权 益 保 护 委 员 会 委 员 2025 年 6 月 10 日 2025 年 ...

卓志先生自2025年6月起担任本公司独立董事。卓志先生曾任西南财经大学 校长、党委副书记，现任西南财经大学中国保险发展研究中心主任、教授，兼任 国务院应用经济学学科评议组成员、教育部金融学类本科教学指导委员会副主任 委员、全国保险专业学位研究生教育指导委员会副主任委员等，同时担任四川农 商联合银行、大家保险集团有限责任公司独立董事。卓先生于1997年取得西南财 经大学货币银行学（保险方向）博士学位，并于1997年至1999年在德国曼海姆大 学进行保险风险管理博士后研究。 特此公告。 新华人寿保险股份有限公司董事会 2025 年 6 月 11 日 | A股证券代码：601336 | | A股证券简称：新华保险 | 编号：2025-031号 | | --- | --- | --- | --- | | H股证券代码： | 01336 | H股证券简称：新华保险 | | 新华人寿保险股份有限公司 关于独立董事任职资格获核准的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"本 ...

執行董事 龔興峰 非執行董事 NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 董事名單與其角色和職能 新華人壽保險股份有限公司董事會（「董事會」）成員載列如下： 董事長、執行董事 楊玉成 董事會下設五個專業委員會，各專業委員會的組成如下： 委員會 董事 戰略與ESG 委員會 投資與資產 負債管理 委員會 審計與關聯 交易控制 委員會 提名薪酬 委員會 風險管理與 消費者權益 保護委員會 楊玉成 C M 龔興峰 M M 楊 雪 M M C 毛思雪 C M 胡愛民 M M 馬耀添 M M 賴觀榮 M M M 徐 徐 M C M 郭永清 C M M 卓 志 M M 楊 雪 毛思雪 胡愛民 獨立非執行董事 馬耀添 賴觀榮 徐 徐 郭永清 卓 志 - 1 - C ：有關專業委員會的主任委員 M ：有關專業委員會的委員 中國北京，2025年6月11日 - 2 - ...

Core Viewpoint - The report from Shenwan Hongyuan indicates that the performance pressure in Q2 is limited, with expectations for improved new business performance and further reductions in the cost of new liabilities due to anticipated interest rate cuts in Q3 [1] Group 1: Market Conditions and Fund Flows - A-share listed insurance companies are significantly underrepresented compared to the CSI 300 index, with public fund regulations expected to drive incremental capital inflows [1] - As of the end of Q1, the allocation of equity funds in the non-bank sector is underweight by 9.68% compared to the CSI 300 index, second only to banks [1] Group 2: New Liability Costs and Product Transformation - The cost of new liabilities has decreased significantly, with some insurance companies optimizing their existing liability costs [2] - The NBV (New Business Value) and VIF (Value of In-Force) yield performances for major insurers show a year-on-year decline, indicating effective risk management of interest spread losses [2] - The transformation of participating insurance products has exceeded expectations, with major insurers elevating this strategy to a strategic level [3] Group 3: Insurance Capital Market Participation - The implementation plan for promoting long-term capital market participation highlights the role of insurance capital as a key player, with sustainable growth in insurance fund utilization expected [4] - The upper limit for equity allocation for insurance capital has been unexpectedly relaxed, allowing for a total equity allocation scale of 9.29 trillion yuan, an increase of 505.5 billion yuan from previous regulations [4] - The reduction of investment risk factors for stock investments further opens up the equity allocation limits for insurance capital [4]

中国的银行保险从1 9 9 6年开始起步。银保产品一直以趸交为主，到2 0 0 7年银保渠道的 新单保费已经超过了所有其他渠道新单保费之和。从2013年到2016年，银保总保费占 寿险行业总规模保费的一半，近几年降到30%左右。最近三年，银保期交保费也逐步赶 上了个险渠道，越发显示出其重要性。 在第一部分，首先回顾了银保业务发展的六个阶段，从2024年开始，进入"报行合一"的 全新阶段。我们汇总了全行业银保新单保费和期交保费数据，另外我们将寿险公司分为 六组，也汇总了每组的保费数据。 在第二部分，我们展示了7 6家寿险公司过去十五年的新单保费和40家大中型公司的行业 排名。我们用亿元做单位，数字0表示保费小于0.5亿元。 这篇文章《银保渠道的过去和未来》是我最近写的研究报告，主要内容分为三个部分在 这里连载。2 0 2 2年初在研究银保渠道时，我选了15家以银保为主并且规模较大的公司， 分为两组，分别称为银保七雄和八大金刚，并且将所有做银保的寿险公司分为六大类， 这种分类对分析银保保费的变化和趋势有很大帮助。 二、2005到2012年 正常增长的时代 根据不完全统计，2005年银保渠道的总保费为9 5 2亿， ...

中央汇金最钟情的是哪些股票？ 创新药题材集中爆发 今日（6月9日），A股超4100股飘红，上证指数最新收盘逼近3400点整数关口。创新药题材热度再次爆棚，常山药业（300255）、海辰药业（300584）、 舒泰神（300204）、睿智医药（300149）收获"20cm"的涨停板；联化科技（002250）、众生药业（002317）、双鹭药业（002038）、昂利康 （002940）、罗欣药业（002793）等录得"10cm"的涨停板。 据证券时报·数据宝统计，截至今日收盘，最新收盘价与近一年低点相比，创新药概念股有11股最大涨幅在200%以上，包括热景生物、舒泰神、常山药 业、益方生物-U、一品红（300723）、三生国健等。 热景生物最大涨幅602.48%，排在第一。该股今日盘中一度涨停，收盘涨幅为18.15%，股价报收161.15元/股，收盘价创历史新高。 公司紧紧围绕创新生物技术，布局从疾病的早期筛查、诊断到治疗的解决方案，相关的体外诊断试剂及仪器是公司的主要产品。今年一季度，公司营业收 入不足1亿元，净利润亏损0.24亿元。 中央汇金金融版图扩容 近日，证监会发布消息，核准中央汇金投资有限责任公司（以 ...

Investment Rating - The report maintains an "Overweight" rating for the non-bank financial sector [1] Core Views - The fundamentals of the non-bank financial sector are improving, with low valuations and expectations for policy catalysts [1] - The insurance sector is expected to benefit from economic recovery and rising interest rates, while the securities sector is poised for growth due to favorable market conditions and policy support [44] Summary by Sections 1. Recent Performance of Non-Bank Financial Sub-Sectors - All sub-sectors of non-bank financials outperformed the CSI 300 index in the recent four trading days, with the securities sector rising by 2.55%, multi-financial by 2.22%, and insurance by 1.03% [8][10] - Year-to-date, the insurance sector has performed the best, followed by multi-financials, while the securities sector has seen a decline [9] 2. Non-Bank Financial Sub-Sector Insights 2.1 Securities - Trading volume has significantly increased year-on-year, with June's average daily trading volume at 13,631 billion yuan, up 65.74% from last year [13] - The China Securities Regulatory Commission (CSRC) is committed to deepening reforms in the capital market, including enhancing the registration system for stock issuance and supporting mergers and acquisitions [17][18] 2.2 Insurance - Life insurance premiums have shown signs of recovery, with original premiums for personal insurance reaching 20,966 billion yuan in the first four months of 2025, a year-on-year increase of 1.8% [20] - The insurance sector's investment in equities has increased, with the total investment balance reaching 34.93 trillion yuan, up 16.7% year-on-year [23] 2.3 Multi-Financial - The trust industry is entering a stable transition period, with total trust assets growing to 29.56 trillion yuan, a year-on-year increase of 23.58% [31] - The futures market saw a significant increase in trading volume and value in April 2025, with a total transaction volume of 8.09 billion contracts and a transaction value of 70.18 trillion yuan, up 21.49% and 23.92% year-on-year, respectively [36] 3. Industry Ranking and Key Company Recommendations - The report ranks the non-bank financial sectors as follows: insurance > securities > other multi-financials, with key recommendations including New China Life Insurance, China Pacific Insurance, China Life Insurance, China Ping An, CITIC Securities, Tonghuashun, and Jiufang Zhitu Holdings [44]

Group 1 - Sunshine Life, along with partners, has established a joint venture to acquire 100% equity in 48 Wanda Plaza projects across major cities in China, with the transaction receiving unconditional approval [1] - This acquisition reflects a trend where insurance companies are increasingly investing in commercial real estate, with Sunshine Life having previously acquired at least six Wanda Plaza projects [1][3] - Insurance companies are becoming a significant force in China's commercial real estate market, with direct investments reaching $9.3 billion from 2022 to 2024, ranking first in the Asia-Pacific region [1] Group 2 - The enthusiasm for commercial real estate investments by insurance funds is driven by the stability and attractive returns of high-quality projects, especially in the current low-interest-rate environment [2][3] - In 2025 Q1, insurance funds have made substantial investments in various commercial real estate sectors, including long-term rentals and retail properties, indicating a shift in asset allocation strategies [3][4] Group 3 - The decline in bond yields has pressured insurance funds to diversify their investments, leading to increased interest in real estate and alternative assets [4] - Insurance funds are exploring various investment channels in commercial real estate, including public REITs, private equity funds, and asset securitization products [4] Group 4 - Insurance companies have significantly increased their stock market investments, with a net purchase of nearly $39 billion in Q1 2025, marking the highest quarterly increase in recent years [5] - The focus on high-dividend stocks, particularly in the banking sector, has been a strategic move by insurance companies in response to the declining interest rates [6] Group 5 - The expansion of long-term investment reform trials for insurance funds has accelerated, with new participants and increased funding amounts, indicating a growing trend towards private fund establishment [7][8] - Recent initiatives have led to the establishment of multiple private funds by major insurance companies, emphasizing long-term and value investment strategies [9][10]

Core Viewpoint - The acceleration of insurance capital entering the market is highlighted by the establishment of new private equity funds, indicating a significant shift towards long-term equity investments by insurance companies in response to regulatory encouragement [2][3][6]. Group 1: Insurance Capital Market Entry - Ping An Asset Management has received approval to establish Hengyi Chiying (Shenzhen) Private Fund Management Co., marking the third insurance private equity manager licensed in China [2][3]. - The total scale of the insurance capital long-term investment reform pilot will increase to 222 billion yuan, with 50 billion yuan already invested and an additional 172 billion yuan in preparation for market entry [3][4]. - The new "National Ten Articles" policy released in September 2024 aims to expand the pilot program, allowing more insurance institutions to establish private equity funds [3][4]. Group 2: Investment Strategies and Focus - Hengyi Chiying will focus on long-term and value investments, targeting high-quality listed companies that align with policy directions and insurance capital needs [3][6]. - Insurance companies are increasingly favoring large-cap, liquid stocks with stable dividends, as seen in the investment strategies of various funds like Honghu Fund [9][10]. - The investment landscape includes a diverse range of sectors, with significant holdings in electronics, pharmaceuticals, machinery, and power equipment, among others [8][10]. Group 3: Regulatory Support and Market Dynamics - Regulatory measures have been implemented to encourage long-term investments, including raising the upper limit for equity asset allocation and adjusting risk factors for stock investments [6][11]. - The establishment of new private equity funds has surged, with several insurance companies launching their funds in May 2025, indicating a robust response to regulatory incentives [6][7]. - The shift towards equity investments is seen as a strategic move for insurance companies to optimize asset allocation, reduce risks, and enhance long-term returns [11][12].